Director's Dealing • Jun 3, 2020
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 8488O
3i Group PLC
03 June 2020
Market Abuse Regulation
MAR Article 19
On 2 June 2020, 3i Group plc (the "Company") was notified of the following.
On 1 June 2020 share awards under the 3i Group Deferred Bonus Plan (the "Plan") held by Simon Borrows, a Director and person discharging managerial responsibilities ("PDMR") vested. On that date 170,718 ordinary shares of 73 19/22p each (ISIN: GB00B1YW4409) in the Company ("Shares") ceased to be subject to restrictions under the Plan.
On 1 June 2020 share awards under the Plan held by the PDMRs named in the table below vested. On that date the Shares shown in the column headed "Shares acquired" ceased to be subject to restrictions under the Plan. The Shares shown in the column headed "Shares sold" were sold on 1 June 2020 at a price of 835.52p per share.
| PDMR | Shares acquired | Shares sold |
| K J Dunn | 61,010 | 28,745 |
| P J White | 314,471 | 314,471 |
| J S Wilson | 74,801 | 35,240 |
| On 1 June 2020 cash settled awards vesting under the Plan (under which a bonus is paid by reference to a number of notional Shares) held by the PDMRs named in the table below became payable. On that date a bonus became payable in respect of a number of notional Shares shown in the column headed "Notional Shares vesting" based on a value equivalent to 827.6p per share. | ||
| PDMR | Notional Shares vesting | |
| R Collins | 6,905 | |
| P De Jong | 18,440 | |
| P Wirtz | 21,837 |
On 1 June 2020 Kevin Dunn, a PDMR, acquired for nil cost 19,470 Shares on the release of a share award under the 3i Group Discretionary Share Plan and sold these Shares on the same date at a price of 835.52p per share.
The place of these transactions was the London Stock Exchange.
Ends
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHUPUBPQUPUGPW
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.